Gallery
Karnataka rain fury: Photos of flooded streets, uprooted trees
Cannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfit
Ranbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A Kiss
Oscars 2022: Every Academy Award Winner
Shane Warne (1969-2022): Australian cricket legend's life in pictures
Photos: What Russia's invasion of Ukraine looks like on the ground
Lata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'
PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Wedding pics: Mouni Roy marries Suraj Nambiar in South Indian ceremony
73rd Republic Day Parade 2022 - In Pictures
The Indian junior women’s hockey team commenced their tour of Europe with a 2-0 victory
- Indian junior men’s and women’s hockey teams leave for tour of Europe
- First Serve, AITA Partner to empower athletes through Wheelchair Tennis Championship
- Bajrang Punia provisionally suspended by NADA, Paris berth at stake: Sources
- Laureus Award 2024 : Novak Djokovic, Aitana Bonmati win top honours at Laureus Sports Awards
- Asian Games medallist Jyothi Yarraji to train in Spain ahead of Paris Olympics
COVID: Biological E gets DCGI nod to conduct phase 2/3 trials on children Last Updated : 02 Sep 2021 11:22:53 AM IST 
The Drug Controller General of India (DCGI) has granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 and 3 clinical trials for its anti-Covid shots called Corbevax on children. The trial will be on children between 5 and 18 years of age with certain conditions.
The permission was given on Wednesday after the recommendation from the Subject Expert Committee.The trial will be conducted in ten locations across the country.The government has made an advance payment of Rs 1,500 crore to Biological E for the 30 crore vaccines.Meanwhile, the trials of Bharat Biotech's Covaxin Covid-19 vaccine for phases 2 and 3 for children are underway, and its result is expected in September.The Zydus Cadila's needle-free Covid-19 vaccine ZyCoV-D has already received emergency use authorisation (EUA) to inoculate children in the age group of 12-18. It is expected to be administered from the first week of October.Meanwhile, the data of phase 2/3 clinical trials of Bharat Biotech's Covaxin in the age group 2 to 18 years is underway.Meanwhile, India reported 47,029 coronavirus cases and 509 deaths in the last 24 hours. With this the country's overall caseload rose to 3.28 crore (3,28,57,937) and the death toll increased to 4.39 lakh (4,39,529).-IANS New Delhi For Latest Updates Please-
Join us on
Follow us on
What binds the two most talked about nations - India and Pakistan together? What makes the
After giving the viral hookstep in the song 'Saami Saami' from 'Pushpa: The Rise', actress
LG Electronics Inc said on Wednesday that it will introduce new C with its artificial inte
172.31.16.186
